Title 42

PART 82

Part 82 - Methods For Conducting Dose Reconstruction Under The Energy Employees Occupational Illness Compensation Program Act Of 2000

PART 82 - METHODS FOR CONDUCTING DOSE RECONSTRUCTION UNDER THE ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION PROGRAM ACT OF 2000 Authority:42 U.S.C. 7384n(d) and (e); E.O. 13179, 65 FR 77487, 3 CFR, 2000 Comp., p. 321. Source:67 FR 22330, May 2, 2002, unless otherwise noted.

42:1.0.1.7.65.1SUBPART A
Subpart A - Introduction
42:1.0.1.7.65.1.15.1SECTION 82.0
   82.0 Background information on this part.
42:1.0.1.7.65.1.15.2SECTION 82.1
   82.1 What is the purpose of this part
42:1.0.1.7.65.1.15.3SECTION 82.2
   82.2 What are the basics of dose reconstruction
42:1.0.1.7.65.1.15.4SECTION 82.3
   82.3 What Are the Requirements for Dose Reconstruction Under EEOICPA
42:1.0.1.7.65.1.15.5SECTION 82.4
   82.4 How Will DOL Use the Results of the NIOSH Dose Reconstructions
42:1.0.1.7.65.2SUBPART B
Subpart B - Definitions
42:1.0.1.7.65.2.15.1SECTION 82.5
   82.5 Definition of terms used in this part.
42:1.0.1.7.65.3SUBPART C
Subpart C - Dose Reconstruction Process
42:1.0.1.7.65.3.15.1SECTION 82.10
   82.10 Overview of the dose reconstruction process.
42:1.0.1.7.65.3.15.2SECTION 82.11
   82.11 For which claims under EEOICPA will NIOSH conduct a dose reconstruction
42:1.0.1.7.65.3.15.3SECTION 82.12
   82.12 Will it be possible to conduct dose reconstructions for all claims
42:1.0.1.7.65.3.15.4SECTION 82.13
   82.13 What sources of information may be used for dose reconstructions
42:1.0.1.7.65.3.15.5SECTION 82.14
   82.14 What types of information could be used in dose reconstructions
42:1.0.1.7.65.3.15.6SECTION 82.15
   82.15 How will NIOSH evaluate the completeness and adequacy of individual monitoring data
42:1.0.1.7.65.3.15.7SECTION 82.16
   82.16 How will NIOSH add to monitoring data to remedy limitations of individual monitoring and missed dose
42:1.0.1.7.65.3.15.8SECTION 82.17
   82.17 What types of information could be used to supplement or substitute for individual monitoring data
42:1.0.1.7.65.3.15.9SECTION 82.18
   82.18 How will NIOSH calculate internal dose to the primary cancer site(s)
42:1.0.1.7.65.3.15.10SECTION 82.19
   82.19 How will NIOSH address uncertainty about dose levels
42:1.0.1.7.65.4SUBPART D
Subpart D - Reporting and Review of Dose Reconstruction Results
42:1.0.1.7.65.4.15.1SECTION 82.25
   82.25 When will NIOSH report dose reconstruction results, and to whom
42:1.0.1.7.65.4.15.2SECTION 82.26
   82.26 How will NIOSH report dose reconstruction results
42:1.0.1.7.65.4.15.3SECTION 82.27
   82.27 How can claimants obtain reviews of their NIOSH dose reconstruction results by NIOSH
42:1.0.1.7.65.4.15.4SECTION 82.28
   82.28 Who can review NIOSH dose reconstruction files on individual claimants
42:1.0.1.7.65.5SUBPART E
Subpart E - Updating the Scientific Elements Underlying Dose Reconstructions
42:1.0.1.7.65.5.15.1SECTION 82.30
   82.30 How will NIOSH inform the public of any plans to change scientific elements underlying the dose reconstruction process to maintain methods reasonably current with scientific progress
42:1.0.1.7.65.5.15.2SECTION 82.31
   82.31 How can the public recommend changes to scientific elements underlying the dose reconstruction process
42:1.0.1.7.65.5.15.3SECTION 82.32
   82.32 How will NIOSH make changes in scientific elements underlying the dose reconstruction process, based on scientific progress
42:1.0.1.7.65.5.15.4SECTION 82.33
   82.33 How will NIOSH inform the public of changes to the scientific elements underlying the dose reconstruction process